|
|
|
Expert Commentary
|
| By Jane Chin, Ph.D. of Jane Chin Associates on Oct 8 2007 1:39PM |
| |
| Andrew Witty, GSK CEO |
| |
GlaxoSmithKline's EU business unit president Andrew Witty beat out other popular candidates David Stout and Chris Viehbacher to become the next CEO for GSK, prompting speculation that the two snubbed candidates may either leave the company for other chief positions or retire (in Stout's case). WSJ's Health Blog noted that Witty was not the top 2 candidates that its readers voted in an earlier poll (I talked about this in my earlier post about whether people care who's next in line as GSK CEO) for as the potential CEO.
The company is taking a positive spin on this by saying that GSK's ability to choose from 3 internal candidates is "testament to its quality management." That keeps future GSK CEO-hopefuls a reason to stick around, I suppose.
|
| |
| Leave a Comment: |
You must be logged in to leave a comment
Log in |
Register
|
|
|
|
|
| |
|
|
|
|
 |
|